Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. rheumatic disease
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Rheumatic Disease Articles & Analysis

4 news found

Phase II update: Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248

Phase II update: Gesynta Pharma announces significant progress across development program for first-in-class drug candidate GS-248

Coordinating Investigator Professor Ariane Herrick, The University of Manchester Centre for Musculoskeletal Research commented: "Systemic sclerosis is a chronic, autoimmune disease that leads to serious damage to the microvessels and which is associated with great unmet need. ...

ByGesynta Pharma AB


Remedica becomes a strategic partner of the Cyprus League against Rheumatism, in the framework of the Join Rheuma Kids Campaign

Remedica becomes a strategic partner of the Cyprus League against Rheumatism, in the framework of the Join Rheuma Kids Campaign

Remedica becomes a strategic partner of the Join Rheuma Kids campaign by the Cyprus League against Rheumatism and on the occasion of the World Day of Youth Rheumatic Diseases, on the 18th of March, Remedica supported the campaign for children with rheumatic diseases. The campaign aims to inform the general ...

ByRemedica Ltd.


Gesynta Pharma initiates Phase II study of its first-in-class drug candidate GS-248 in patients with systemic sclerosis

Gesynta Pharma initiates Phase II study of its first-in-class drug candidate GS-248 in patients with systemic sclerosis

Study results are expected towards the end of 2021 and will provide the basis for future clinical trials both in systemic sclerosis and potentially other chronic inflammatory diseases. Systemic sclerosis is a progressive, autoimmune disease that leads to serious damage to the microvasculature. ...

ByGesynta Pharma AB


First recipients of research grants to support genomic studies in Africa announced

African scientists will conduct genomic research on kidney disease, diabetes, heart disease, obesity, tuberculosis and African sleeping sickness through inaugural grants of the Human Heredity and Health in Africa Consortium (H3Africa). ...

ByNational Institute of Environmental Health Sciences (NIEHS)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT